When It Comes To Healthcare Costs, New Medicines Are The Solution, Not The...
All healthcare stakeholders should work together to eliminate cost-sharing hurdles that may discriminate against patients who need care the most.
View ArticleWhy Medication Adherence Needs To Be A National Priority
For all the dizzying talk of repeal versus repair, one of the greatest cost drivers in healthcare is still hiding in plain sight.
View ArticleSen. Elizabeth Warren: Why CEOs Should Fight The Senate's Healthcare Bill
No family will escape the reach of the Republican repeal of our healthcare laws. And yet America’s CEOs look the other way.
View ArticleCAR-T Cell Therapy Is Here To Stay
After decades of research and development, we’re on the brink of a new era in the treatment of cancer, one where nearly every aspect—from the patient experience to the efficacy of treatments—may be...
View ArticlePfizer CEO: The Future Of American Innovation Rests On A Competitive U.S. Tax...
We want to build a future of innovation as rich as our history. A tax system that creates a level playing field for all companies will make the vision a reality.
View ArticleNovartis CEO: Here's How We Handled A Milestone In Pediatric Cancer
Immunotherapies are opening new ways to treat cancer, enabling us to target disease like never before and in cancers where progress has been elusive for years. Here, Novartis's chief executive explains...
View ArticleHow To Cure An Infectious Disease In The World's Poorest Countries
Gilead Sciences EVP Gregg Alton: Can lessons learned from HIV be applied to hepatitis C?
View ArticleNovartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs
Patients and the entire U.S. healthcare system deserve to benefit from biosimilars.
View ArticleAre Social Determinants The Missing Key To Improving Health?
As we think of clinical contributors to health, social determinants of health must become equally as important.
View ArticlePfizer CEO: How The Biopharmaceutical Industry Creates Value (And Jobs) For...
The most fundamental way in which the industry creates value is by discovering and manufacturing innovative medicines that help people live longer, healthier, more productive lives.
View ArticleRegeneron CEO & CSO: The Real Healthcare Problem Is Bigger Than You Think
We have grown increasingly concerned about the current dialogue on the biopharma industry, which tends to focus on short-term issues such as drug pricing, at the complete exclusion of much bigger...
View Article
